Rani Therapeutics (NASDAQ:RANI) Price Target Lowered to $4.00 at Oppenheimer
Rani Therapeutics (NASDAQ:RANI – Free Report) had its price target trimmed by Oppenheimer from $14.00 to $4.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research analysts have also weighed in on RANI. HC Wainwright reaffirmed a “buy” rating and issued […]
Rani Therapeutics (NASDAQ:RANI – Free Report) had its price target trimmed by Oppenheimer from $14.00 to $4.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research analysts have also weighed in on RANI. HC Wainwright reaffirmed a “buy” rating and issued […]
